10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
65.05
+5.77 (9.73%)
Nov 9, 2026, 4:00 PM EST - Market closed

10x Genomics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-67.08-43.54-182.63-255.1-166-58.22
Depreciation & Amortization
46.8143.8243.7143.6233.0128.25
Asset Writedown & Restructuring Costs
-0.813.059.85--
Loss (Gain) From Sale of Investments
--01.72--
Stock-Based Compensation
96.57109.12140.75166.95136.8595.96
Other Operating Activities
10.510.910.520.431.960.08
Change in Accounts Receivable
-11.9241.3126.95-10.61-18.95-34.04
Change in Inventory
-0.9227.95-9.787.87-21.19-30.13
Change in Accounts Payable
3.53-2.13-3.35-6.025.8611.08
Change in Unearned Revenue
-1.920.7511.2110.933.351.54
Change in Other Net Operating Assets
24.13-42.95-23.7815.17-8.49-35.89
Operating Cash Flow
99.7136.056.66-15.2-33.61-21.37
Operating Cash Flow Growth
12.63%1941.57%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-5.93-5.94-12.39-48.6-131.66-101.28
Cash Acquisitions
-6.75-9.27---4-5.45
Sale (Purchase) of Intangibles
---1-0.92--
Investment in Securities
1.331.77-19.24183.02-215.23-
Investing Cash Flow
-11.35-13.44-32.63133.49-350.89-106.73

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
----5.81-5.41-5.03
Total Debt Repaid
----5.81-5.41-5.03
Net Debt Issued (Repaid)
----5.81-5.41-5.03
Issuance of Common Stock
14.066.810.9119.4821.2340.33
Financing Cash Flow
5.376.810.9113.6715.8235.3

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.240.48-0.16-0.03-0.040.23
Net Cash Flow
93.48129.9-15.22131.93-368.72-92.57

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
93.77130.12-5.73-63.8-165.27-122.65
Free Cash Flow Growth
14.84%-----
Free Cash Flow Margin
15.16%20.24%-0.94%-10.31%-32.00%-25.01%
Free Cash Flow Per Share
0.731.04-0.05-0.55-1.45-1.11
Levered Free Cash Flow
122.82148.3959.227.63-92.66-67.02
Unlevered Free Cash Flow
122.82148.3959.227.65-92.36-66.48

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
---0.440.841.22
Cash Income Tax Paid
2.232.395.644.933.938.66
Change in Working Capital
12.8924.941.2517.34-39.42-87.45
SEC Filings: 10-K · 10-Q